Latest Biotech News

Caris Life Sciences submitted an application to the New York State Department of Health for CLEP authorization to run its Caris Assure blood-based genomic profiling test on specimens from New...

Odyssey Therapeutics completed its IPO and raised $304 million for its quest to develop immunology drugs, with ulcerative colitis named as the lead indication for an internally discovered pipeline...

A new update tracks Odyssey’s move to Nasdaq and situates the listing among broader biotech equity activity, including follow-ons by multiple clinical-stage companies. The report notes that...

Researchers reported a phase II signal in cancer of unknown primary (CUP) using a second-line regimen that pairs an anti–PD-1 immune checkpoint inhibitor with nab-paclitaxel. The work, led by...

Researchers unveiled a technique that dissects cell-free DNA fragment-size patterns to detect tumor-linked nucleosomal alterations. The approach leverages “fragmentomics”—the relationship between...

A Northwestern University-led study reported preclinical evidence that metformin’s glucose-lowering effects in mice are tied primarily to action in the gut rather than solely the liver. Published...

The US Department of Justice announced a new “West Coast” healthcare fraud strike force covering Arizona, Nevada and Northern California, targeting rising risks tied to Medicaid, hospice, and...

Multiple reports say President Donald Trump plans to fire FDA Commissioner Marty Makary, though the plan is not finalized. If executed, the move would end Makary’s tenure, which has included...

Moderna has reportedly started early-stage work on a hantavirus vaccine, with the effort conducted in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases and Korea...

Multiple reports say President Donald Trump plans to fire FDA Commissioner Marty Makary, though the decision is not finalized and could change. The alleged move would end Makary’s roughly yearlong...

Caris Life Sciences submitted an application to the New York State Department of Health’s Clinical Laboratory Evaluation Program for authorization to perform Caris Assure on specimens originating...

Odyssey Therapeutics priced an IPO and concurrent private placement totaling $304 million gross to advance lead programs in inflammatory bowel disease and expand next indications. The company’s...

Mobia Medical began trading on Nasdaq after pricing its IPO at $15 per share, raising about $150 million. The company’s lead therapy, Vivistim Paired VNS, is a vagus-nerve stimulation approach...

10x Genomics filed a lawsuit against Element Biosciences alleging patent infringement tied to Element’s Aviti24 multiomic platform. The complaint, filed in U.S. District Court for the District of...

10x Genomics announced Atera, a new in situ spatial biology platform positioned to deliver whole-transcriptome spatial analysis with single-cell sensitivity at scale. The company said Atera is...

Scarlet Therapeutics closed a $4 million seed round to advance manufactured red blood cells (RBCs) into a first clinical application. The company said its RBCs function in vivo like natural cells...

Tr1X is developing off-the-shelf type 1 regulatory T cell therapies for difficult-to-treat inflammatory and immune-mediated diseases, with a lead candidate in Phase I/II testing. The program is...

Amplified Sciences initiated patient enrollment for PanAMP, a multicenter real-world clinical utility study evaluating its PanCystPro assay’s effect on clinical decision-making for early...

The FDA has granted accelerated approval to Regeneron’s Otarmeni (lunsotogene parvec-cwha), positioning it as the first gene therapy designed to restore neurosensory function to normal levels in...

Moderna began early-stage work on a hantavirus vaccine, according to reports that sparked a notable investor reaction. The Boston Globe and other outlets described the program as still in its...